Ironwood Pharmaceuticals, Inc.
IRWD
$0.57
-$0.0244-4.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.34M | 880.00K | -2.46M | 9.21M | -1.05B |
| Total Depreciation and Amortization | 1.98M | 2.01M | 2.04M | 1.64M | 1.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 91.65M | 100.30M | 99.17M | 104.58M | 1.16B |
| Change in Net Operating Assets | 17.24M | 361.00K | 25.43M | 31.32M | 34.87M |
| Cash from Operations | 78.52M | 103.55M | 124.17M | 146.74M | 148.24M |
| Capital Expenditure | -105.00K | -142.00K | -353.00K | -386.00K | -328.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -3.98M | -26.55M | -1.03B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -105.00K | -142.00K | -4.33M | -26.94M | -1.03B |
| Total Debt Issued | 150.00M | 150.00M | 150.00M | 150.00M | 400.00M |
| Total Debt Repaid | -240.00M | -265.00M | -275.00M | -325.00M | -125.00M |
| Issuance of Common Stock | 958.00K | 11.01M | 11.81M | 11.82M | 12.44M |
| Repurchase of Common Stock | -121.00K | -737.00K | -737.00K | -737.00K | -616.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.25M | -2.25M | -29.06M | -26.90M | -29.20M |
| Cash from Financing | -91.41M | -106.97M | -142.99M | -190.82M | 257.62M |
| Foreign Exchange rate Adjustments | -63.00K | -32.00K | -103.00K | -80.00K | -29.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.06M | -3.60M | -23.25M | -71.10M | -620.54M |